OBGYN.net Editorial Advisor
Executive Advisory Board
Obstetrics, Pregnancy & Birth
Fibroid Resource Center & Discussion Forum
Women's Health Forum

Richard Martin Chudacoff, MD, PhD - USA
Articles and Interviews on OBGYN.net by Dr.
Chudacoff
Website: Las Vegas International Center for Advanced Gynecologic Care
Office:
Las Vegas International Center for Advanced Gynecologic Care
(Specializing in minimally and non-invasive surgery)
2481 Professional Court
Las Vegas, NV 89128
Tel: 702-485-8893
Fax: 702-974-0945
Email: rchudacoff@lasvegasgyncenter.com
Assistant Professor
Department of Obstetrics and Gynecology
University of Nevada School of Medicine
2040 W. Charleston Blvd # 200
Las Vegas, Nevada 89102
Email:
rchudacoff@medicine.nevada.edu
Professional Focus:
Minimally invasive surgery; pelvic reconstruction; urogynecology; MRI guided focused ultrasound
Present Positions:
Las Vegas International Center for Advanced Gynecologic Care
Founder- February 2007
ExAblate of Las Vegas (2/2007-Present)
Partner
Mountain View Medical Center (2/2007-Present)
Las Vegas
Attending PhysicianSummerlin Medical Center (2/2007-Present)
Summerlin/Las Vegas
Attending Physician
National Medical Director (3/2005- Present)
Sound Medical Solutions
Deployed Medical Solutions
Houston, TXOBGYN.net Executive Advisory Board http://www.obgyn.net/meet.asp?page=exec-board
Editorial Advisory Board - OBGYN.net Obstetrics, Pregnancy & Birth Section http://www.obgyn.net/pb/pb.asp
Editorial Advisory Board/Fibroid Forum Hero - Fibroid Resource Center
http://www.obgyn.net/fibroid-resource-center
Lecturer:
Organon
Johnson and Johnson’s Women’s Health Division
Past Position:
Women’s Specialist of Houston (4/2005-2/2007)
Associate Physician
Great Houston Hospitalists, LLC (6/2005-2/2007)
Attending and Co-Founder
Houston, TX
Clinical Assistant Professor, Dept. OB/GYN (1/2000-present)
Baylor College of Medicine, Houston, TX
Attending Physician (04/05-present)
Dept. OB/GYN
St. Luke’s Episcopal Hospital
Houston, TX
Attending Physician (04/05-present)
Dept. OB/GYN
The Methodist Hospital
Houston, TX
Attending Physician (09/03-present)
Dept. OB/GYN
Sugar Land Surgical Hospital
Sugar Land, TX
Owner:
Chudacoff Obstetrics & Gynecology, PA (2000-2005)
Sugar Land, TX
Assistant Professor, Dept. OB/GYN (1996-2000)
Baylor College of Medicine, Houston, TX
Medical Director (1996-2000)
BaylorMedCare, New Territory
Sugar Land, TX
Chairman, Dept. Of OB/GYN/PEDS (1998)
Chairman, Utilization Review/Medical Records Committee (1999)
Chairman, Tumor Board/Case Conference (1998-99)
Medical Executive Committee (1998)
Credentials Committee (1998-99)
Continuing Education Committee (1998-99)
Co-Sponsor, CME Program (with Baylor College of Medicine) (1998-99)
Polly Ryon Memorial Hospital, Richmond, TX
Director, SANE (Sexual Abuse Nurse Examiners) Program
Ft. Bend County, Texas (1997-2000)
Past Experience:
Military
8/27/90-8/31/93
Residency: National Naval Medical Center, Bethesda, MD
9/1/93-10/31/95
Attending Physician, Dept. OB/GYN
Naval Hospital, Rota, Spain
LCDR (select), Medical Corps, USNR
Discharge: 10/31/95 Honorable
Education and Professional Training:
Collegiate:
UC Santa Barbara BA-Biology 1/81-5/83
San Diego State University 9/79-5/80
Cal St. U. -Northridge 9/77-5/78Graduate:
UC Santa Barbara Phys/Cell Biology 1/84-5/84Medical:
Albany Medical College MD 8/86-5/89
Sackler School of Medicine 8/84-5/86
Tel Aviv, IsraelInternship:
Internal Medicine 7/89-6/90
Kaiser Permanente Medical Center
Los Angeles, CAResidency:
Obstetrics and Gynecology 8/90-8/93
National Naval Medical Center
Bethesda Naval Hospital
Bethesda, MD
MRI physics and interpretation for ExAblate 2000 MRI guided focused ultrasound users 5/05Certification:
MR Guided Focused Ultrasound Surgery
1/06
Licensure/Board Status:
National Board of Medical Examiners
Medical Board of California
Texas State Board of Medical Examiners
American Board of Obstetrics and Gynecology: Board Certified
Organizations:
American College of Obstetricians and Gynecologist: Fellow
American Medical Association
Houston Gynecological and Obstetrical Society
Texas Association of Obstetricians and Gynecologists –Fellow
Harris County Medical Society
Interests: Golf, Tennis, Scuba Diving, Photography, Sailing, Traveling, Volleyball
Bibliography:
1. Bennett JA, Peters JH, Chudacoff RM, McKneally MF. Endogenous Production Of Cytotoxic Factors In Serum Of BCG-Primed Mice By Monophosphoryl Lipid-A, A Detoxified Form Of Endotoxin. Journal Of Biological Response Modifiers 1988;7:65-76
2. Chudacoff RM, Taylor R. Streptococcus pneumonea Pelvic Inflammatory Disease. A Case Report: Journal Of Reproductive Medicine 1995;40:649-651
3. Chudacoff, RM, Alexander J, Alvero R, Segar JH. Tissue Expansion Vaginoplasty For The Treatment Of Congenital Vaginal Agenesis. Obstetrics And Gynecology 1996;87:865-868
4. Peritoneal Adhesions: Clinical Significance, Prevention and Management. Recent Advances in Reduction. A short Analytical Review. (Pending acceptance)
5. MR guided Focused Ultrasound Surgery; Article US Obstetrics & Gynecology 2007 - Issue II-pending publication
Research Experience:
1. Efficacy Study Comparing 0.9 g and 1.25 g EstroGel 0.03% Doses with Placebo in the treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated with Menopause
2. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to evaluate the efficacy and safety of synthetic conjugated estrogens, (Enjuvia) 0.3 mg tablets for the treatment of Vulvovaginal trophy in Healthy Postmenopausal Women.
3. Comparison of the Safety and Efficacy of a Unique Intravenous Iron Preparation (VIT-45) versus Oral Iron in the Treatment of Iron Deficiency Anemia Secondary to Heavy Uterine Bleeding.
4. Comparison of the Safety and Efficacy of a Unique Intravenous Iron Preparation (VIT-45)versus Oral Iron and Subject to Display Postpartum Anemia.
5. A Phase II, Multicenter Double-Blind, and Randomized, Placebo Controlled Study to Evaluate Induction of Withdrawal Bleeding After the Administration of Oral Micronized Progesterone Women with Secondary Amenorrhea DR-MPG-201.
6. A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial Demonstrating Safety and Efficacy of Daily 0.3 mg Synthetic Conjugated Estrogens, A (Cenestin)for the Treatment of Vasomotor Symptoms in Postmenopausal Women DR-CEN-301

Articles
Register for 